Natco Pharma Complete Financial Statements
NATCOPHARM • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Natco Pharma (NATCOPHARM).
Downloads include all available records across all periods.
For market performance, see the
NATCOPHARM stock price today
.
Profitability Ratios
Net Profit Margin
35.41%
2025 data
EBITDA Margin
46.41%
2025 data
Operating Margin
42.00%
2025 data
Return on Assets
6.00%
2025 data
Return on Equity
6.81%
2025 data
Balance Sheet Ratios
Current Ratio
70.27
2025 data
Debt to Equity
1.13
2025 data
Equity Ratio
88.19%
2025 data
Asset Turnover
0.17
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
+2.0%
Year-over-Year
Net Profit Growth
-23.5%
Year-over-Year
EBITDA Growth
-21.8%
Year-over-Year
Expense Growth
+38.3%
Year-over-Year
Assets Growth
+25.0%
Year-over-Year
Equity Growth
+30.1%
Year-over-Year
Liabilities Growth
+25.0%
Year-over-Year
Operating Cash Flow Growth
+40.0%
Year-over-Year
Investing Cash Flow Growth
-40.1%
Year-over-Year
Financing Cash Flow Growth
+14.6%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Mar 2018 | Jun 2018 | Dec 2018 | Sept 2017 | Mar 2017 | Jun 2017 | Dec 2017 | Sept 2016 | Mar 2016 | Jun 2016 | Dec 2016 | Sept 2015 | Mar 2015 | Jun 2015 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,463 | 1,287 | 1,391 | 1,435 | 1,110 | 1,411 | 651 | 1,061 | 927 | 1,160 | 796 | 453 | 611 | 919 | 513 | 415 | 360 | 427 | 591 | 828 | 477 | 582 | 386 | 519 | 487 | 513 | 513 | 584 | 788 | 575 | 580 | 432 | 564 | 432 | 574 | 464 | 395 | 330 | 676 | 239 | 194 | 218 | 281 |
| Expenses | 784 | 673 | 758 | 567 | 571 | 558 | 436 | 573 | 559 | 613 | 491 | 337 | 615 | 489 | 387 | 307 | 255 | 301 | 459 | 526 | 327 | 392 | 273 | 351 | 307 | 301 | 354 | 323 | 385 | 321 | 348 | 305 | 324 | 291 | 276 | 356 | 302 | 248 | 410 | 185 | 151 | 166 | 227 |
| EBITDA | 679 | 614 | 633 | 868 | 539 | 853 | 215 | 487 | 368 | 548 | 305 | 116 | -5 | 430 | 127 | 109 | 105 | 127 | 132 | 302 | 151 | 190 | 113 | 168 | 179 | 212 | 160 | 261 | 403 | 254 | 232 | 127 | 241 | 140 | 298 | 108 | 93 | 82 | 266 | 54 | 42 | 51 | 54 |
| Operating Profit Margin % | 42.00% | 45.00% | 43.00% | 59.00% | 47.00% | 59.00% | 8.00% | 44.00% | 38.00% | 46.00% | 35.00% | 22.00% | -3.00% | 45.00% | 22.00% | 19.00% | 23.00% | 27.00% | 18.00% | 34.00% | 28.00% | 30.00% | 23.00% | 28.00% | 33.00% | 39.00% | 27.00% | 41.00% | 50.00% | 40.00% | 37.00% | 29.00% | 43.00% | 32.00% | 51.00% | 23.00% | 23.00% | 24.00% | 39.00% | 22.00% | 21.00% | 23.00% | 17.00% |
| Depreciation | 52 | 98 | 58 | 46 | 56 | 44 | 47 | 44 | 41 | 44 | 44 | 42 | 38 | 40 | 42 | 35 | 30 | 34 | 36 | 29 | 31 | 28 | 30 | 22 | 22 | 22 | 25 | 20 | 18 | 18 | 21 | 16 | 14 | 15 | 17 | 14 | 12 | 13 | 14 | 13 | 13 | 13 | 13 |
| Interest | 13 | 10 | 3 | 4 | 6 | 5 | 4 | 4 | 3 | 4 | 5 | 4 | 7 | 4 | 4 | 4 | 4 | 2 | 5 | 3 | 4 | 4 | 3 | 6 | 5 | 7 | 5 | 5 | 3 | 3 | 6 | 4 | 6 | 4 | 4 | 4 | 4 | 3 | 5 | 8 | 9 | 8 | 4 |
| Profit Before Tax | 614 | 506 | 572 | 818 | 478 | 804 | 164 | 440 | 324 | 500 | 256 | 70 | -50 | 386 | 81 | 70 | 71 | 91 | 91 | 271 | 117 | 158 | 80 | 139 | 152 | 184 | 129 | 235 | 382 | 232 | 205 | 107 | 221 | 121 | 276 | 90 | 77 | 66 | 248 | 40 | 31 | 38 | 50 |
| Tax | 96 | 100 | 92 | 142 | 91 | 135 | 31 | 71 | 49 | 80 | 44 | 14 | 1 | 65 | 19 | 5 | 18 | 16 | 11 | 67 | 24 | 36 | 17 | 22 | 32 | 41 | 24 | 54 | 83 | 51 | 45 | 23 | 44 | 28 | 59 | 24 | 14 | 19 | 53 | 11 | -23 | 11 | 13 |
| Net Profit | 518 | 406 | 480 | 677 | 386 | 669 | 132 | 369 | 276 | 420 | 213 | 57 | -51 | 320 | 62 | 65 | 53 | 75 | 80 | 204 | 93 | 122 | 63 | 118 | 120 | 143 | 104 | 182 | 300 | 181 | 159 | 84 | 176 | 94 | 217 | 66 | 63 | 48 | 195 | 29 | 53 | 27 | 37 |
| Earnings Per Share (₹) | 28.94 | 22.70 | 26.84 | 37.81 | 21.56 | 37.32 | 7.43 | 20.60 | 15.11 | 23.26 | 11.88 | 3.11 | -2.77 | 22.55 | 3.41 | 3.57 | 2.91 | 4.11 | 4.41 | 11.12 | 5.17 | 6.74 | 3.44 | 6.55 | 6.59 | 7.87 | 5.75 | 9.89 | 16.26 | 9.84 | 8.65 | 4.82 | 10.10 | 5.59 | 12.29 | 3.79 | 3.86 | 2.74 | 11.18 | 9.05 | 16.41 | 1.70 | 2.13 |
Related Pages for Natco Pharma
Additional stock information and data for NATCOPHARM
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 8,631 | 6,906 | 5,657 | 5,109 | 4,792 | 4,588 | 4,303 | 3,715 | 2,318 | 1,822 | 1,384 |
| Current Assets | 5,270 | 4,024 | 3,000 | 2,487 | 2,345 | 2,326 | 2,347 | 2,131 | 1,087 | 837 | 483 |
| Fixed Assets | 2,698 | 2,491 | 2,427 | 2,312 | 2,023 | 1,584 | 1,227 | 1,019 | 833 | 710 | 710 |
| Capital Work in Progress | 225 | 137 | 64 | 130 | 223 | 518 | 638 | 480 | 336 | 212 | 129 |
| Investments | 474 | 539 | 392 | 308 | 304 | 112 | 169 | 77 | 32 | 22 | 0 |
| Other Assets | 5,234 | 3,739 | 2,774 | 2,360 | 2,242 | 2,373 | 2,270 | 2,140 | 1,116 | 878 | 545 |
| LIABILITIES | |||||||||||
| Total Liabilities | 8,631 | 6,906 | 5,657 | 5,109 | 4,792 | 4,588 | 4,303 | 3,715 | 2,318 | 1,822 | 1,384 |
| Current Liabilities | 75 | 80 | 101 | 135 | 143 | 118 | 83 | 47 | 38 | 28 | 119 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 7,612 | 5,853 | 4,874 | 4,264 | 4,123 | 3,785 | 3,491 | 3,076 | 1,653 | 1,301 | 851 |
| Share Capital | 36 | 36 | 37 | 37 | 37 | 36 | 37 | 37 | 35 | 35 | 33 |
| Reserves & Surplus | 7,571 | 5,817 | 4,837 | 4,227 | 4,085 | 3,737 | 3,453 | 3,035 | 1,614 | 1,261 | 813 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 1,697 | 1,212 | 849 | 47 | 299 | 417 | 669 | 464 | 346 | 112 | 93 |
| Investing Activities | -1,437 | -1,026 | -465 | 4 | -107 | -175 | -611 | -1,116 | -299 | -176 | -120 |
| Financing Activities | -211 | -247 | -363 | 35 | -186 | -251 | -51 | 651 | -48 | 154 | 29 |
| Net Cash Flow | 50 | -62 | 21 | 85 | 6 | -9 | 7 | -2 | -1 | 90 | 2 |